Nannan Zhu
About Nannan Zhu
Nannan Zhu is the Associate Director of SSU and CM at BeiGene in Beijing, with extensive experience in clinical trial management and a strong background in oncology.
Current Role as Associate Director at BeiGene
Nannan Zhu currently holds the position of Associate Director of SSU and CM at BeiGene in Beijing. In this role, she is responsible for managing the study start-up (SSU) and clinical management (CM) processes. She has been instrumental in the successful implementation of Good Clinical Practice (GCP) standards at BeiGene, ensuring the highest quality of clinical trials.
Previous Experience at IQVIA
Nannan Zhu has an extensive tenure at IQVIA, where she progressed through various roles over eight years. Her roles included CRA Trainee, CRA, Associate Line Manager, Manager, Sr. Manager, and Sr. Study Manager. She demonstrated expertise in managing clinical trials and played a key role in various oncology-related projects. Her responsibilities grew progressively, indicating her capability in handling complex clinical management tasks.
Early Career in Nursing
Nannan Zhu's career began in the healthcare sector as a Nursing Assistant at Astley Ainslie Hospital in Edinburgh, where she worked for five years. She then moved on to work as a Staff Nurse at the Royal Infirmary Edinburgh and 北京同仁医院 (Beijing Tongren Hospital). These roles provided her with a solid foundation in patient care and clinical processes.
Educational Background
Nannan Zhu holds a Bachelor of Science (BSc) in Nursing from Queen Margaret University, obtained between 2005 and 2007. She also studied Nursing at Capital University of Medical Sciences from 1998 to 2001. Her educational background has equipped her with the theoretical knowledge and practical skills necessary for her roles in clinical management and healthcare.
Expertise in Clinical Trials and Oncology
Nannan Zhu has a wealth of experience in managing clinical trials and study start-up processes. Her background in oncology has allowed her to contribute significantly to various oncology-related projects. She is adept at people management, leading teams to achieve project milestones, and has a thorough understanding of the biotechnology industry. Her expertise enables her to drive business development initiatives effectively.